Related Experiment Video
Updated: Sep 5, 2025
08:56
A Method for Measuring RNA N6-methyladenosine Modifications in Cells and Tissues
Published on: December 5, 2016
11.0K
N6-methyladenosine (m6A) modification in gynecological malignancies
1Department of Obstetrics and Gynecology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, China.
Journal of Cellular Physiology
|July 8, 2022
Summary
N6-methyladenosine (m6A) RNA modification is crucial in gynecologic cancers. Aberrant m6A molecules impact gene stability and tumor growth, offering new diagnostic and therapeutic targets.
Area of Science:
- Molecular Biology
- Epigenetics
- Oncology
Background:
- N6-methyladenosine (m6A) is a prevalent mRNA modification in eukaryotes, regulated by methyltransferases and demethylases.
- m6A modification influences RNA processing, including splicing, maturation, degradation, and translation, via specific recognition proteins.
- Aberrant expression of m6A-related molecules is observed in gynecologic malignancies, affecting gene stability and tumor progression.
Purpose of the Study:
- To review the composition and function of m6A modification-related proteins in gynecologic malignancies.
- To analyze the role of m6A modification in the malignant progression of gynecologic cancers.
- To explore the potential of m6A modification for early diagnosis and targeted therapy.
Main Methods:
- Literature review of m6A modification-related proteins and their functions.
- Analysis of the impact of m6A modification on gene expression and stability in gynecologic cancers.
- Synthesis of current knowledge on m6A pathways in gynecologic malignancy development.
Main Results:
- m6A modification regulators are aberrantly expressed in gynecologic malignancies.
- Altered m6A levels impact target gene stability and metabolic pathways, influencing tumor development.
- m6A modification plays a significant role in the malignant progression of gynecologic cancers.
Conclusions:
- m6A RNA modification-related molecules are key players in gynecologic malignancies.
- Understanding m6A modification offers novel strategies for early clinical diagnosis.
- Targeted therapies focusing on m6A pathways present promising avenues for gynecologic cancer treatment.
Related Concept Videos
01:46Epigenetic Regulation
31.3K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.3K
02:23RNA Editing
9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
01:35Pre-mRNA Processing: Modification of pre-mRNA Ends
9.7K
In eukaryotic cells, transcripts made by RNA polymerase are modified and processed before exiting the nucleus. Unprocessed RNA is called precursor mRNA or pre-mRNA to distinguish it from mature mRNA.
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
Once about 20-40 ribonucleotides have been joined together by RNA polymerase, a group of enzymes adds a cap to the 5' end of the growing transcript. In this process, a 5' phosphate is replaced by modified guanosine that has a methyl group attached (7-methyl guanosine). This 5' cap helps...
9.7K
01:22MicroRNAs
3.1K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
02:31Nuclear Export of mRNA
7.8K
Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.8K